AVEO Pharmaceuticals, Inc.
🏢 View company profile →40Patents
39Active
40Granted
53Portfolio score
Filing activity: Aug 27, 2004 → Jun 16, 2023 · 14 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8187601B2 | Fibroblast growth factor receptor 3 (FGFR3) binding proteins | Chemistry; Metallurgy | 30 | Active |
| US7649083B2 | Hepatocyte growth factor (HGF) binding antibody | Chemistry; Metallurgy | 19 | Active |
| US8481687B2 | Anti-ErbB3 antibodies | Chemistry; Metallurgy | 16 | Active |
| US9175076B2 | Anti-GDF15 antibodies | Chemistry; Metallurgy | 9 | Active |
| US7659378B2 | Hepatocyte growth factor (HGF) binding antibody | Chemistry; Metallurgy | 9 | Active |
| US9879083B2 | Anti-Notch3 antibodies | Chemistry; Metallurgy | 8 | Active |
| US7544476B1 | Identifying cancers sensitive to treatment with inhibitors of notch signaling | Chemistry; Metallurgy | 8 | Active |
| US8481688B2 | Anti-FGFR2 antibodies | Chemistry; Metallurgy | 7 | Active |
| US9725505B2 | Methods of treatment using anti-GDF15 antibodies | Chemistry; Metallurgy | 6 | Active |
| US9228021B2 | Anti-ErbB3 antibodies | Chemistry; Metallurgy | 5 | Active |
| US7935502B2 | Hepatocyte growth factor (HGF) binding proteins | Chemistry; Metallurgy | 5 | Active |
| US7943344B2 | Hepatocyte growth factor (HGF) binding proteins | Chemistry; Metallurgy | 5 | Active |
| US8603478B2 | Anti-RON antibodies | Chemistry; Metallurgy | 4 | Active |
| US9828635B2 | Predicting tumor response to anti-ERBB3 antibodies | Physics | 3 | Active |
| US8273355B2 | Hepatocyte growth factor (HGF) binding proteins | Chemistry; Metallurgy | 3 | Active |
| US8268315B2 | Hepatocyte growth factor (HGF) binding proteins | Chemistry; Metallurgy | 3 | Active |
| US10494441B2 | Anti-ERBB3 antibodies | Chemistry; Metallurgy | 3 | Active |
| US9896730B2 | Use of EMT gene signatures in cancer drug discovery, diagnostics, and treatment | Chemistry; Metallurgy | 3 | Active |
| US10745476B2 | Anti-NOTCH3 antibodies | Chemistry; Metallurgy | 3 | Active |
| US7736861B1 | Tivozanib response prediction | Physics | 2 | Active |
| US10597444B2 | Anti-GDF15 antibodies | Chemistry; Metallurgy | 2 | Active |
| US8373017B2 | Reconstituted human breast tumor model | Chemistry; Metallurgy | 2 | Active |
| US8575318B2 | Hepatocyte growth factor (HGF) binding proteins | Chemistry; Metallurgy | 1 | Active |
| US9096664B2 | Nucleic acid encoding hepatocyte growth factor (HGF) binding proteins | Chemistry; Metallurgy | 1 | Active |
| US9598498B2 | Anti-ErbB3 antibodies | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.